These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30792003)

  • 21. Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10-year review of the Memorial Sloan-Kettering Cancer Center experience (1972-1981).
    Lawhead RA; Clark DG; Smith DH; Pierce VK; Lewis JL
    Gynecol Oncol; 1989 Jun; 33(3):279-82. PubMed ID: 2722049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
    Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
    Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies.
    Husain A; Curtin J; Brown C; Chi D; Hoskins W; Poynor E; Alektiar K; Barakat R
    Gynecol Oncol; 2000 Aug; 78(2):208-11. PubMed ID: 10926804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
    Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
    World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of pelvic exenteration for gynecologic malignancies.
    Moolenaar LR; van Rangelrooij LE; van Poelgeest MIE; van Beurden M; van Driel WJ; van Lonkhuijzen LRCW; Mom CH; Zaal A
    Gynecol Oncol; 2023 Apr; 171():114-120. PubMed ID: 36870097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pelvic exenteration--our initial experience in 15 cases.
    Căpîlna ME; Moldovan B; Szabo B
    Eur J Gynaecol Oncol; 2015; 36(2):142-5. PubMed ID: 26050350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of gynecologic oncology patients in King Chulalongkorn Memorial Hospital - complications and outcome of pelvic exenteration.
    Oranratanaphan S; Termrungruanglert W; Sirisabya N
    Asian Pac J Cancer Prev; 2013; 14(4):2529-32. PubMed ID: 23725169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: time to change back?
    Backes FJ; Tierney BJ; Eisenhauer EL; Bahnson RR; Cohn DE; Fowler JM
    Gynecol Oncol; 2013 Jan; 128(1):60-64. PubMed ID: 22892363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pelvic exenteration in gynecologic oncology: a single institution study over 20 years.
    Benn T; Brooks RA; Zhang Q; Powell MA; Thaker PH; Mutch DG; Zighelboim I
    Gynecol Oncol; 2011 Jul; 122(1):14-8. PubMed ID: 21444105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies.
    Mourton SM; Chi DS; Sonoda Y; Alektiar KM; Venkatraman ES; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2006 Mar; 100(3):533-6. PubMed ID: 16226800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies.
    Urh A; Soliman PT; Schmeler KM; Westin S; Frumovitz M; Nick AM; Fellman B; Urbauer DL; Ramirez PT
    Gynecol Oncol; 2013 Jun; 129(3):580-5. PubMed ID: 23480870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pelvic exenteration: impact of age on surgical and oncologic outcomes.
    Huang M; Iglesias DA; Westin SN; Fellman B; Urbauer D; Schmeler KM; Frumovitz M; Ramirez PT; Soliman PT
    Gynecol Oncol; 2014 Jan; 132(1):114-8. PubMed ID: 24262877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of pelvic exenteration for treatment of pelvic malignancy--a nine-year experience.
    Wydra D; Emerich J; Ciach K; Sawicki S; Marciniak A
    Eur J Gynaecol Oncol; 2005; 26(4):418-22. PubMed ID: 16122192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.
    Tortorella L; Casarin J; Mara KC; Weaver AL; Multinu F; Glaser GE; Cliby WA; Scambia G; Mariani A; Kumar A
    Gynecol Oncol; 2019 Jan; 152(1):151-156. PubMed ID: 30414740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary vaginal reconstruction at the time of pelvic exenteration for gynecologic cancer: morbidity revisited.
    Jurado M; Bazán A; Alcázar JL; Garcia-Tutor E
    Ann Surg Oncol; 2009 Jan; 16(1):121-7. PubMed ID: 18941843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and management of major urinary complications after pelvic exenteration for gynecological malignancies.
    Bladou F; Houvenaeghel G; Delpéro JR; Guérinel G
    J Surg Oncol; 1995 Feb; 58(2):91-6. PubMed ID: 7844989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pelvic Exenteration in Advanced Gynecologic Malignancies - Who Will Benefit?
    Egger EK; Liesenfeld H; Stope MB; Recker F; Döser A; Könsgen D; Marinova M; Hilbert T; Exner D; Ellinger J; Mustea A
    Anticancer Res; 2021 Jun; 41(6):3037-3043. PubMed ID: 34083295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients.
    Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Fagotti A; Fanfani F; Parazzini F; Schiavina R; Scambia G; Schneider A; Vercellino GF
    Int J Gynecol Cancer; 2014 Jan; 24(1):156-64. PubMed ID: 24362721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of continent urinary diversion after pelvic exenteration for gynecologic malignancies.
    Karsenty G; Moutardier V; Lelong B; Guiramand J; Houvenaeghel G; Delpero JR; Bladou F
    Gynecol Oncol; 2005 May; 97(2):524-8. PubMed ID: 15863155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical and psychosexual outcome following vaginal reconstruction with pelvic exenteration.
    Gleeson N; Baile W; Roberts WS; Hoffman M; Fiorica JV; Barton D; Cavanagh D
    Eur J Gynaecol Oncol; 1994; 15(2):89-95. PubMed ID: 8005148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.